华大基因发布前三季度业绩，归母净亏损2138.7万元

Core Insights - BGI Genomics (300676.SZ) reported a revenue of 2.674 billion yuan for the first three quarters of 2025, representing a year-on-year decline of 5.39% [1] - The company recorded a net loss attributable to shareholders of 21.387 million yuan [1] - The net loss attributable to shareholders, excluding non-recurring gains and losses, was 66.7647 million yuan [1]